DoD Peer Reviewed Orthopaedic Clinical Trial Development Award
The PRORP Clinical Trial Development Award (CTDA) is intended to support the planning and development activities necessary to support preparation for clinical trials with the potential to have a significant impact on military combat-related orthopaedic injuries. The clinical trials proposed may be focused on any aspect of treatment of combat-related orthopaedic injuries that addresses the FY13 PRORP CTDA Focus Areas outlined below, including the evaluation of promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. All applications are required to justify the relevance of the proposed project to military and/or Veteran populations affected by combat-related orthopaedic injury. Collaboration with military researchers and clinicians is encouraged, and studies that plan to include active duty military or Veteran participants as all or a portion of the study population will be given higher priority for funding during programmatic review.
Office: U.S. Army Medical Research Acquisition Activity
